Literature DB >> 11641195

Negative predictive value of sonography with mammography in patients with palpable breast lesions.

M S Soo1, E L Rosen, J A Baker, T T Vo, B A Boyd.   

Abstract

OBJECTIVE: This study was performed to determine the negative predictive value of sonography with mammography in evaluating palpable breast lesions.
MATERIALS AND METHODS: Four hundred twenty patients with 455 palpable breast lesions were retrospectively identified from our mammography database as having negative mammographic and sonographic results. For patients diagnosed with breast cancer, images and medical records were reviewed to determine whether the palpable lesion evaluated on sonography and mammography corresponded to the patient's breast cancer. On the basis of the number of breast cancers that correlated to the palpable areas imaged, the negative predictive value of sonography with mammography was determined.
RESULTS: Sixty-two of the 420 patients in the study group were already diagnosed with breast carcinoma, and eight new carcinomas were diagnosed during the study period. Only one of six ipsilateral cancers corresponded to a palpable lesion that had a negative imaging evaluation. This lesion was diagnosed as an invasive lobular cancer, hard and fixed at physical examination. Imaging and clinical follow-up of the remaining patients showed no abnormality at the sites of previously investigated palpable abnormalities. The mean imaging follow-up was 25 months. The negative predictive value of sonography and mammography in the setting of a palpable lesion was 99.8%.
CONCLUSION: The negative predictive value of sonography with mammography is high, and together these imaging modalities can be reassuring if follow-up is planned when the physical examination is not highly suspicious. However, if the physical examination is suspicious, biopsy should not be delayed.

Entities:  

Mesh:

Year:  2001        PMID: 11641195     DOI: 10.2214/ajr.177.5.1771167

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  Incorporating new imaging models in breast cancer management.

Authors:  Denise H Reddy; Ellen B Mendelson
Journal:  Curr Treat Options Oncol       Date:  2005-03

2.  Automated analysis of breast parenchymal patterns in whole breast ultrasound images: preliminary experience.

Authors:  Yuji Ikedo; Takako Morita; Daisuke Fukuoka; Takeshi Hara; Gobert Lee; Hiroshi Fujita; Etsuo Takada; Tokiko Endo
Journal:  Int J Comput Assist Radiol Surg       Date:  2009-03-14       Impact factor: 2.924

3.  Is there a role for magnetic resonance imaging in diagnosing palpable breast masses when mammogram and ultrasound are negative?

Authors:  Molly L Olsen; Marilyn J Morton; Daniela L Stan; Sandhya Pruthi
Journal:  J Womens Health (Larchmt)       Date:  2012-10-09       Impact factor: 2.681

4.  Bilateral orbital tumour as the presentation of mammographically occult breast cancer.

Authors:  M Lell; R Schulz-Wendtland; A Hafner; A Magener; W A Bautz; B F Tomandl
Journal:  Neuroradiology       Date:  2004-07-08       Impact factor: 2.804

Review 5.  BI-RADS 3: Current and Future Use of Probably Benign.

Authors:  Karen A Lee; Nishi Talati; Rebecca Oudsema; Sharon Steinberger; Laurie R Margolies
Journal:  Curr Radiol Rep       Date:  2018-01-27

6.  A Low-Cost, Low-Skill Model for Efficient Breast Cancer Screening in Low Resource Rural Settings of a Developing Country.

Authors:  Sachin Khanduri; Mriganki Chaudhary; Tushar Sabharwal; Tarim Usmani; Aakshit Goyal; Shobha Khanduri; Saurav Bhagat; Fahimul Huda; Santosh Yadav; Gaurav Katyal
Journal:  Cureus       Date:  2017-08-16

7.  Breast cancer imaging in South Africa in 2018.

Authors:  Peter K Schoub
Journal:  SA J Radiol       Date:  2018-11-05

8.  Diagnostics in Patients Suspect for Breast Cancer in The Netherlands.

Authors:  Madelon M Voets; Catharina G M Groothuis-Oudshoorn; Liset H J Veneklaas; Srirang Manohar; Mariël Brinkhuis; Jeroen Veltman; Linda de Munck; Lioe-Fee de Geus-Oei; Mireille J M Broeders; Sabine Siesling
Journal:  Curr Oncol       Date:  2021-11-29       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.